Tiziana Life Sciences back under the spotlight... - Part 4
There will be plenty of small cap punters watching Tiziana Life Sciences this morning after it released details of a new study on StemPrintER, its stem cell biology-based genomic tool for the prediction of disease recurrence in breast cancer patients, at the ASCO conference last night.
Date:Thursday, 14 May 2020 7:38 am
